Summarize This Guide with AI
The page title, key topics and source link are passed to your selected tool in a prepared prompt.

There is no single risk profile or recovery timetable for “penile aesthetics”. Hyaluronic acid filler, glans injection, fat transfer, suspensory ligament surgery, suprapubic surgery and scrotoplasty involve different tissues and different complications. Early swelling or bruising may be expected after some procedures, while severe pain, rapidly increasing swelling, fever, progressive skin discoloration, difficulty urinating or tissue breakdown can indicate a complication that needs prompt assessment. The procedure, anatomy, medical history and healing conditions all matter.
Why do risks vary between patients and procedures?
Risk is influenced by more than the name of the procedure. Relevant factors can include:
- whether treatment is injectable or surgical;
- the material used;
- the anatomical layer being treated;
- previous fillers or operations;
- scar tissue;
- diabetes and vascular disease;
- smoking or nicotine exposure;
- active infection or inflammatory skin disease;
- medications that affect bleeding;
- postoperative wound care and follow-up;
- expectations and willingness to accept uncertainty.
This is why complication figures from one technique should not be presented as the expected rate for another.
A 2026 systematic review and meta-analysis of penile augmentation procedures found highly heterogeneous evidence across techniques and materials. Even pooled complication estimates should therefore be interpreted cautiously rather than as a personal risk calculator.
What can be expected early after a procedure, and what may signal a complication?
Some degree of temporary swelling, tenderness or bruising may occur after many injections and operations. The pattern should generally stabilize and improve rather than progressively worsen.
Features that deserve reassessment include:
- pain that is severe or increasing rather than settling;
- rapidly expanding swelling;
- marked asymmetry developing after an initially stable result;
- increasing redness, warmth or discharge;
- fever;
- persistent bleeding;
- skin that becomes unusually pale, dusky, dark or blistered;
- new urinary difficulty;
- wound separation;
- a new hard, painful or inflamed nodule.
The threshold for assessment should be lower when symptoms change rapidly.
What are the main risks of penile filler?
For injectable penile girth enhancement, reported and clinically relevant complications include:
- swelling and bruising;
- uneven distribution or asymmetry;
- palpable nodules or irregularity;
- inflammation or infection;
- migration or displacement of material;
- dissatisfaction with contour or volume;
- need for correction or removal;
- vascular compromise or tissue injury, although serious events are uncommon in published HA series.
Hyaluronic acid is biodegradable and can be treated with hyaluronidase in selected complications, but “reversible” should not be interpreted as free of risk or instantly correctable.
Read about penile filler and how filler volume is assessed.
Are glans filler risks different?
They can be. The glans has a different vascular and tissue anatomy from the penile shaft. Hyaluronic acid glans injection has been studied mainly in premature-ejaculation research rather than as general cosmetic enlargement.
The EAU notes evidence of efficacy for HA glans injection in premature ejaculation but recommends caution compared with established treatment options because serious complications have been reported and more safety evidence is needed.
Potential problems include pain, swelling, infection, nodularity, altered sensation, asymmetry and vascular/tissue injury.
What can happen after autologous fat transfer?
Fat transfer uses the patient’s own adipose tissue, but autologous does not mean complication-free. Relevant risks include:
- variable fat survival and resorption;
- contour irregularity or asymmetry;
- nodules;
- fat necrosis or oil cyst formation;
- infection;
- swelling or haematoma;
- need for additional treatment.
Published long-term data remain limited, and the retained volume cannot be assumed to be fixed.
Read about penile fat transfer.
What are the risks of penile lengthening surgery?
Suspensory ligament release has a different risk profile from filler or fat transfer. Potential complications include:
- bleeding and infection;
- scar problems;
- chronic pain or altered sensation;
- altered erection angle;
- reduced support or perceived instability;
- reattachment or retraction;
- loss of part of an initial visible gain;
- dissatisfaction;
- revision surgery.
The principal limitation is also conceptual: it should not be presented as a predictable way to add a fixed amount of erect penile length.
Read about penile lengthening surgery.
What are the risks of suprapubic procedures and buried-penis reconstruction?
These operations range from limited liposuction to larger skin/fat excision and complex reconstructive surgery. Risks can include:
- seroma;
- haematoma;
- infection;
- wound separation;
- delayed healing;
- scar problems;
- contour irregularity;
- persistent or recurrent concealment;
- graft-related problems in reconstructive cases.
Men with obesity, diabetes, chronic inflammatory skin disease or extensive scarring can have additional wound-healing challenges.
Read about buried penis and suprapubic fat.
Does scrotoplasty have the same recovery and risk profile?
No. Scrotoplasty deals with scrotal skin and/or the penoscrotal junction. Risks may include swelling, bleeding, infection, wound breakdown, asymmetry, unwanted scarring, altered sensation, residual laxity or need for revision.
The evidence base for aesthetic scrotoplasty is particularly limited and is mostly made up of case reports and technique descriptions. It should not be grouped with penile injection procedures simply because both are described as genital aesthetic surgery.
Who may not be suitable for an elective genital aesthetic procedure?
A procedure may need to be postponed, reconsidered or avoided when there is:
- active genital infection;
- untreated inflammatory skin disease;
- uncontrolled diabetes or another major medical risk;
- significant bleeding risk;
- heavy nicotine exposure that compromises wound healing;
- unresolved complications from a previous filler or operation;
- expectations that cannot reasonably be met by the procedure;
- severe body-image distress or suspected body dysmorphic disorder.
Not having a contraindication is not the same as having a positive indication for treatment.
What if there are active genital warts or HPV-related lesions?
Active genital warts, ulceration, infection or uncertain lesions should be assessed before an elective injection or operation through the affected area. The priority is diagnosis and appropriate management of active disease rather than proceeding with aesthetic treatment.
HPV itself is common and can persist without visible lesions, so suitability cannot be reduced to a simple “HPV positive/negative” rule.
Read about genital warts and HPV.
What information matters before treatment?
A pre-procedure assessment can include:
- the exact anatomical complaint;
- objective measurements when relevant;
- erection and sexual function;
- skin and soft-tissue quality;
- previous injections, fillers and operations;
- medical conditions and medications;
- infection or inflammatory disease;
- smoking/nicotine use;
- body-image expectations;
- the patient’s understanding of alternatives, including no intervention.
A request for “more length” or “more girth” should be translated into a precise anatomical target before an irreversible decision is made.
Why does body-image assessment matter?
Most men seeking enlargement do not have micropenis. Some have normal measurements but remain highly distressed about size. The EAU recommends screening for body dysmorphic disorder or penile dysmorphic disorder in men with normal penile size who remain focused on perceived inadequacy.
This does not mean a cosmetic concern is automatically psychological. It means objective anatomy and the intensity of distress should both be understood before a procedure is recommended.
How should recovery be discussed?
Recovery should be procedure-specific rather than presented as one generic schedule. Important variables include:
- injection versus open surgery;
- size and location of wounds;
- use of grafts or drains;
- degree of swelling;
- combined procedures;
- return to work and activity demands;
- sexual activity restrictions;
- wound-healing risk.
The treating clinician’s instructions should take precedence over generic online timelines.
What can impair healing?
Factors that can increase the likelihood of delayed healing or complications include:
- smoking and nicotine;
- poorly controlled diabetes;
- obesity in operations involving the pubic region;
- active infection;
- poor local skin condition;
- repeated trauma or premature return to strenuous activity;
- unreported medications or supplements affecting bleeding;
- complex previous surgery or scar tissue.
What happens if a complication occurs?
Management depends on the problem. It may involve observation, medication, drainage, hyaluronidase for selected HA-related issues, wound care, imaging, surgical revision or other targeted treatment.
A person who has had treatment elsewhere should still provide the exact product name, amount if known, date, anatomical sites and any previous attempts at correction. Guessing the material can make assessment more difficult.
Which warning signs need urgent assessment?
Prompt or emergency assessment is appropriate for:
- severe or rapidly increasing pain;
- rapidly expanding swelling;
- fever with spreading redness;
- skin turning markedly pale, purple, dark or black;
- blistering or tissue breakdown;
- inability to urinate;
- heavy bleeding;
- wound separation with exposed deeper tissue;
- sudden loss of sensation or pronounced coldness;
- a prolonged painful erection lasting four hours or more.
Can risk be eliminated completely?
No medical procedure has zero risk. Good patient selection, sterile technique, anatomical knowledge, appropriate materials and follow-up may reduce risk, but they cannot remove uncertainty.
The 2026 evidence synthesis also underlines that comparative data are limited and that complication reporting is inconsistent across penile augmentation studies.
Why can the final result not be predicted exactly?
Tissue response, swelling, scar formation, filler behavior, fat survival, reattachment and healing differ between people. For that reason, a medically responsible discussion should focus on the range of plausible outcomes and limitations rather than a predetermined measurement or appearance.
Medical information note
This page compares risk categories across several procedures. It does not imply that the procedures have equal evidence, equal risk or equal recovery. Individual assessment and procedure-specific informed consent remain necessary.
Sources6 sources
2026
European Association of Urology. *EAU Guidelines on Sexual and Reproductive Health — Penile Size Abnormalities and Dysmorphophobia*. 20262026
European Association of Urology. *EAU Guidelines on Sexual and Reproductive Health — Disorders of Ejaculation*. 20262026
Fonseca TDF, Querobino SM. *Penile augmentation procedures: a systematic review and meta-analysis of techniques, materials, and safety outcomes*. Sex Health. 2026. PMID: 42402428PubMed: 42402428
2020
Marra G, et al. *Systematic Review of Surgical and Nonsurgical Interventions in Normal Men Complaining of Small Penis Size*. Sex Med Rev. 2020. PMID: 31027932PubMed: 31027932
2021
Thomas C, Navia A. *Aesthetic Scrotoplasty: Systematic Review and a Proposed Treatment Algorithm for the Management of Bothersome Scrotum in Adults*. Aesthetic Plast Surg. 2021. PMID: 33057830PubMed: 33057830
2020
Smith-Harrison LI, Piotrowski J, Machen GL, Guise A. *Acquired Buried Penis in Adults: A Review of Surgical Management*. Sex Med Rev. 2020. PMID: 31101591PubMed: 31101591